Journal article
Ethical challenges for a new generation of early-phase pediatric gene therapy trials
Genetics in medicine, Vol.23(11), pp.2057-2066
11/2021
DOI: 10.1038/s41436-021-01245-3
PMID: 34234300
Abstract
After decades of setbacks, gene therapy (GT) is experiencing major breakthroughs. Five GTs have received US regulatory approval since 2017, and over 900 others are currently in development. Many of these GTs target rare pediatric diseases that are severely life-limiting, given a lack of effective treatments. As these GTs enter early-phase clinical trials, specific ethical challenges remain unresolved in three domains: evaluating risks and potential benefits, selecting participants fairly, and engaging with patient communities. Drawing on our experience as clinical investigators, basic scientists, and bioethicists involved in a first-in-human GT trial for an ultrarare pediatric disease, we analyze these ethical challenges and offer points to consider for future GT trials.
Details
- Title: Subtitle
- Ethical challenges for a new generation of early-phase pediatric gene therapy trials
- Creators
- Alexander A Iyer - National Institutes of Health Clinical CenterDimah Saade - National Institute of Neurological Disorders and StrokeDiana Bharucha-Goebel - National Institute of Neurological Disorders and StrokeA Reghan Foley - National Institute of Neurological Disorders and StrokeGilberto 'Mike' Averion - National Institute of Neurological Disorders and StrokeEduardo Paredes - National Institute of Neurological Disorders and StrokeSteven Gray - The University of Texas Southwestern Medical CenterCarsten G Bönnemann - National Institute of Neurological Disorders and StrokeChristine Grady - National Institutes of Health Clinical CenterSaskia Hendriks - National Institutes of Health Clinical CenterAnnette Rid - National Institutes of Health Clinical Center
- Resource Type
- Journal article
- Publication Details
- Genetics in medicine, Vol.23(11), pp.2057-2066
- DOI
- 10.1038/s41436-021-01245-3
- PMID
- 34234300
- NLM abbreviation
- Genet Med
- ISSN
- 1098-3600
- eISSN
- 1530-0366
- Language
- English
- Date published
- 11/2021
- Academic Unit
- Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Neurology (Pediatrics)
- Record Identifier
- 9984354151802771
Metrics
36 Record Views